Brachytherapy Devices Market

The brachytherapy devices market is projected to increase from US$ 343.57 million in 2024 to US$ 534.20 million by 2031, with an estimated CAGR of 6.7% from 2025 to 2031.

Analyst Perspective

Brachytherapy, or internal radiation therapy (IRT), involves placing radioactive devices such as seeds, ribbons, wires, needles, capsules, balloons, or tubes close to tumors to deliver concentrated doses of radiation. This method is effective in destroying and reducing tumors. Unlike other radiation therapies, brachytherapy allows for higher radiation doses while minimizing harm to adjacent organs. The rising incidence of cancers significantly drives the growth of the brachytherapy devices market. Furthermore, advancements in technology and the increasing use of IRTs for cancer treatment are also contributing to market expansion. However, the risks associated with brachytherapy and a shortage of skilled technicians pose challenges to market growth.

Market Overview

The growing incidence of cancers, such as breast, prostate, and cervical cancer, is a key factor driving the brachytherapy devices market. According to data released by the World Health Organization (WHO) in February 2024, approximately 20 million new cancer cases and 9.7 million cancer-related deaths were reported worldwide in 2022. Among these, breast cancer was the most prevalent, with 2.3 million cases diagnosed in women. Prostate and colorectal cancers rank as the second and third most common cancers in men, respectively. Brachytherapy devices are commonly utilized to effectively treat gynecologic, prostate, breast, and various other cancers. These devices, which include wires, seeds, or rods containing radioactive materials, are implanted near tumors to deliver radiation over a specific distance.

Additionally, brachytherapy is generally quicker and has fewer side effects compared to other radiation therapies. A study published by Elsevier in June 2023 compared the outcomes of brachytherapy with external beam radiation therapy (EBRT) using a large multi-institutional database, revealing that brachytherapy is associated with better survival rates and a lower incidence of distant cancer metastases compared to EBRT. This finding is crucial and may promote the adoption of brachytherapy as a cost-effective and efficient treatment for patients with intermediate- to high-risk prostate cancer.

As the global cancer prevalence continues to rise, the demand for brachytherapy as a widely accessible treatment option significantly contributes to the growth of the brachytherapy devices market.

Strategic Insights

Report Segmentation and Scope

The brachytherapy devices market analysis has been conducted considering the following segments: product type, type, application, and end user.

The market is segmented by product type into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. By

type, the market is divided into high-dose rate brachytherapy implants and low-dose rate brachytherapy implants. The market is also segmented by application into breast cancer, cervical cancer, prostate cancer, lung cancer, and others.
By end user, the market is categorized into hospitals and specialty clinics, ambulatory surgical centers, and others.

The scope of the global brachytherapy devices market report includes North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Insights by Product Type

Based on product type, the brachytherapy devices market is divided into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. The brachytherapy afterloaders and applicators segment held the largest market share in 2022 and is expected to exhibit the highest CAGR from 2022 to 2030.

Insights by Type

The market is categorized by type into high-dose brachytherapy implants and low-dose rate brachytherapy implants. The low-dose rate brachytherapy implant segment accounted for a larger share of the brachytherapy devices market in 2022 and is projected to grow at a faster CAGR from 2022 to 2030.

Insights by Application

The brachytherapy devices market is segmented by application into breast cancer, cervical cancer, prostate cancer, lung cancer, and others. The prostate cancer segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022 to 2030.

Insights by End User

By end user, the market is divided into hospitals and specialty clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022, attributed to the availability of superior facilities and skilled physicians in hospitals compared to other surgical centers for performing minimally invasive procedures.

Regional Analysis

Geographically, the market is segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. North America led the brachytherapy devices market in terms of revenue in 2022, primarily driven by the US. This dominance is due to several factors, including the rising incidence of breast cancer among women and prostate cancer among men in the region. According to the Pan America Health Organization (PAHO), approximately 4 million people in the Americas were diagnosed with cancer in 2020, with projections indicating a ~60% increase by 2040.

Moreover, the presence of key market players such as BD, Isoray Inc., and Elekta, along with the availability of advanced brachytherapy devices, presents significant opportunities for market growth. For example, in July 2021, GenesisCare expanded its brachytherapy services by acquiring 27 Flexitron brachytherapy afterloader systems and service agreements from Elekta, enabling them to stay updated with the latest technology and provide high-quality care to patients across their centers in the US.

Brachytherapy Devices Market Report Scope

Industry Developments and Future Opportunities:

The brachytherapy devices market forecast can assist stakeholders in planning their growth strategies. According to company press releases, several strategic developments by leading players in the global market are highlighted below:

1. In October 2023, Elekta announced the acquisition of the Xoft business from iCAD, Inc. through an asset acquisition. This acquisition of the Xoft Axxent Electronic Brachytherapy (eBx) System, along with the transfer of employees, aims to enhance the range of cancer treatment options and electronic brachytherapy technology offered by the company.
2. In July 2023, CIVCO Radiotherapy announced a partnership with Qfix, a company specializing in devices for patient positioning and immobilization, during the American Society for Radiation Oncology (ASTRO) Annual Meeting held from October 23-26, 2022, in San Antonio, Texas.
3. In July 2022, BEBIG Medical acquired Wolf-Medizintechnik GmbH (WOmed), a German company that provides advanced X-ray therapy and newly developed intraoperative radiation therapy products globally. This acquisition aimed to enhance BEBIG Medical's product offerings in radiation therapy for cancer treatment.
4. In December 2020, Varian Medical Systems, Inc. launched four new brachytherapy applicator sets for HDR brachytherapy targeting the vagina, cervix, uterus, endometrium, and rectum. These new applicators are designed to address size, usability, and MRI imaging support issues, making them more user-friendly and comfortable for patients, thus allowing clinicians to treat more patients on an outpatient basis.

Key companies profiled in the brachytherapy devices market report include Elekta, Varian Medical Systems, Inc., BEBIG Medical, Theragenics Corporation, IsoAid, Siemens Healthineers AG, BXTA, BD, Eckert and Ziegler, and Perspective Therapeutics. These leading players are focused on expanding and diversifying their market presence and clientele, seizing business opportunities in the market.

This product will be delivered within 3-5 business days.